How Much Is a CRISPR Patent License Worth? – Forbes
Forbes |
How Much Is a CRISPR Patent License Worth?
Forbes Last Wednesday, the Patent Trial and Appeal Board (PTAB) ruled in favor of the Broad Institute in the most monumental biotech patent dispute in decades: a patent "interference" trial over foundational patents covering CRISPR-Cas9, a revolutionary … |
